Please login to the form below

Not currently logged in
Email:
Password:

treatment access

This page shows the latest treatment access news and features for those working in and with pharma, biotech and healthcare.

First blood to Roche in Hemlibra patent fight with Shire

First blood to Roche in Hemlibra patent fight with Shire

to continue to have access to the treatment”.

Latest news

More from news
Approximately 1 fully matching, plus 190 partially matching documents found.

Latest Intelligence

  • Working with our healthcare system more closely is vital Working with our healthcare system more closely is vital

    Take a recent local NHS partnership aimed at addressing specific access and capacity issues in Southampton. ... to essential treatment, expanding and improving care for people living with a leading cause of vision loss – age-related macular

  • Simplifying HCP access to digital information Simplifying HCP access to digital information

    Simplifying HCP access to digital information. New industry-standards group launched. The life science industry’s commercial model has transformed significantly over the past decade. ... This new standard will improve how life science companies

  • The gold standard of scientific evidence The gold standard of scientific evidence

    By randomising access to the treatment, researchers would be able to measure efficacy using robust statistical methods. ... Even social media data can be used to measure real-world treatment safety and effectiveness.

  • The real-world data conundrum The real-world data conundrum

    treatment options, access for populations in developing countries and an up-to-date evidence-base is ever increasing. ... when healthcare professionals will be able to provide the right treatment, for the right person, at the right dose, at the right time

  • Exploring serious market access roadblocks for rare bleeding disorders Exploring serious market access roadblocks for rare bleeding disorders

    Exploring serious market access roadblocks for rare bleeding disorders. Ensuring that sufferers get the treatment they require. ... More complete data will also help pharmaceutical companies to justify drivers of treatment costs - a key element when it

More from intelligence
Approximately 1 fully matching, plus 37 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 20 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Transforming healthcare outsourcing. From small beginnings in 1997, Ashfield has grown rapidly into an international healthcare services organisation. By anticipating...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics